Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifabutin vs Rifampicin for Staphylococcal Prosthetic Joint Infection (RIFAMAB)
NCT04672525Phase 3Recruiting
- Sponsor
- Centre Hospitalier de Tourcoing
- Start
- Nov 2021
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rifabutin in prosthetic joint infection (PJI), sponsored by Centre Hospitalier de Tourcoing. Started Nov 2021; status: recruiting.
02
Drugs
rifabutin
03
Conditions
prosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT04672525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04672525.